Treace Medical Concepts, Inc. Insider Trading

TMCI

⊜ Compare

Last 12 months

Insiders bought $1.24M on the open market and sold nothing.

Net open-market

+$1.24M

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

1 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 24, 2026

Get an email when TMCI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 20 – 24	John T. Treace Chief Executive Officer	Bought 3 parts	55,944	$4.41 average	247K	0.4%	Form 4
Jun 10 – 11	John T. Treace Chief Executive Officer	Bought 2 parts	24,606	$4.03 average	99K	0.2%	Form 4
Jun 1	John T. Treace Chief Executive Officer	Bought	50,000	$3.56	178K	0.4%	Form 4
May 26 – 28	John T. Treace Chief Executive Officer	Bought 3 parts	115,520	$2.95 average	340K	0.9%	Form 4
May 12 – 14	John T. Treace Chief Executive Officer	Bought 3 parts	153,763	$2.44 average	376K	1.2%	Form 4
Mar 17, 2025	Sean F. Scanlan Chief Innovation Officer	Sold10b5-1 plan	50,000	$7.97	399K	12%	Form 4
Mar 4, 2025	John T. Treace Chief Executive Officer	Bought	60,000	$8.73	524K	0.5%	Form 4

Aug 20 – 24
John T. Treace
Chief Executive Officer · bought 55,944 at avg $4.41
247K
0.4% of stake
Jun 10 – 11
John T. Treace
Chief Executive Officer · bought 24,606 at avg $4.03
99K
0.2% of stake
Jun 1
John T. Treace
Chief Executive Officer · bought 50,000 at $3.56
178K
0.4% of stake
May 26 – 28
John T. Treace
Chief Executive Officer · bought 115,520 at avg $2.95
340K
0.9% of stake
May 12 – 14
John T. Treace
Chief Executive Officer · bought 153,763 at avg $2.44
376K
1.2% of stake
Mar 17, 202510b5-1 plan
Sean F. Scanlan
Chief Innovation Officer · sold 50,000 at $7.97
399K
12% of stake
Mar 4, 2025
John T. Treace
Chief Executive Officer · bought 60,000 at $8.73
524K
0.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TMCI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with TMCI

CompareIntrinsic value

SIBNSi-Bone Inc.

$24.95+4.96%40

HTFLHeartFlow, Inc.

$56.57+3.99%49

CERSCerus Corporation

$2.42+3.21%32

KIDSOrthoPediatrics Corp.

$33.51+6.69%45

STIMNeuronetics Inc.

$2.71+19.69%30

LMATLemaitre Vascular Inc.

$87.89+9.04%72

INFUInfuSystem Holdings Inc.

$13.15+2.73%59

XTNTXtant Medical Holdings Inc.

$0.30+7.14%15

Held by ETFs

TMCI is in 2 US ETFs. The largest of them, with TMCI's weight in each:

Spot a number that looks wrong? Check it in TMCI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TMCI

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.